Document:

Form of Notice of Grant of Stock Option

 Exhibit 10.7 
 PDL BIOPHARMA, INC. 
 NOTICE OF GRANT OF STOCK OPTION 
 The Participant has been granted an option (the “Option”) to purchase certain shares of Stock of PDL BioPharma, Inc. pursuant to
the PDL BioPharma, Inc. 2005 Equity Incentive Plan (the “Plan”), as follows: 
  

			
	 Participant:
	  	_____________
		
	 Date of Grant:
	  	_____________
		
	 Number of Option Shares:
	  	_____________
		
	 Exercise Price:
	  	$                        
		
	 Initial Vesting Date:
	  	The date one (1) year after <<insert vesting commencement date>>
		
	 Option Expiration Date:
	  	The date seven (7) years after the Date of Grant
		
	 Tax Status of Option:
	  	Nonstatutory Stock Option
		
	 Vested Shares:
	  	Except as provided in the Stock Option Agreement, the number of Vested Shares (disregarding any resulting fractional share) as of any date is determined by multiplying the Number of Option
Shares by the “Vested Ratio” determined as of such date as follows:
		
		  	Vested Ratio
		
		  	Prior to Initial Vesting Date
		
		  	On Initial Vesting Date, provided the Participant’s Service has not terminated prior to such date
		
		  	 Plus

		
		  	For each additional full month of the Participant’s continuous Service from Initial Vesting Date until the Vested Ratio equals 1/1, an additional
		
	 Adjustments to Vested Ratio:
	  	The Company may adjust the Vested Ratio to account for any periods of part-time Service as an Employee.
		
	 Termination of Unvested
 Option:
	  	Except as may otherwise be provided by the Board, upon termination of the Participant’s Service as an Employee, the Option shall terminate immediately with respect to shares that are not
Vested Shares. However, provided the Participant’s Service continues uninterrupted in a capacity other than as an Employee, the Option shall continue in accordance with the terms of the Stock Option Agreement with respect to any Vested Shares.
Upon termination of the Participant’s Service, the Option shall terminate in accordance with the terms of the Stock Option Agreement.

 By their signatures below or by electronic acceptance or authentication in a form authorized by the Company, the
Company and the Participant agree that the Option is governed by this Grant Notice and by the provisions of the Plan and the Stock Option Agreement, both of which are made a part of this document. The Participant acknowledges that copies of the
Plan, the Stock Option Agreement and the prospectus for the Plan are available on the Company’s internal web site and may be viewed and printed by the Participant for attachment to the Participant’s copy of this Grant Notice. The
Participant represents that the Participant has read and is familiar with the provisions of the Plan and the Stock Option Agreement, and hereby accepts the Option subject to all of their terms and conditions. 
  

							
	 PDL BIOPHARMA, INC.
	 		 	PARTICIPANT
				
	 By:
	 	  
	 		 	  

		 		 		 	Signature
				
	 Its:
	 	  
	 		 	  

		 		 		 	Date
				
	 Address:
	 	 34801 Campus Drive
	 		 	  

		 	 Fremont, California 94555
	 		 	Address
				
		 		 		 	  

  

			
	 ATTACHMENTS:
	 	2005 Equity Incentive Plan, as amended to the Date of Grant; Stock Option Agreement, Exercise Notice and Plan ProspectusForm of Stock Option Agreement

 Exhibit 10.8 
 PDL BIOPHARMA, INC. 
 STOCK OPTION AGREEMENT 
 PDL BioPharma, Inc. has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant
Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the
terms and conditions set forth in the Grant Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the PDL BioPharma, Inc. 2005 Equity Incentive Plan (the
“Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the
Participant has read and is familiar with the Grant Notice, this Option Agreement, the Plan and a prospectus for the Plan in the form most recently registered with the Securities and Exchange Commission (the “Plan
Prospectus”), (b) accepts the Option subject to all of the terms and conditions of the Grant Notice, this Option Agreement and the Plan and (c) agrees to accept as binding, conclusive and final all decisions or
interpretations of the Committee upon any questions arising under the Grant Notice, this Option Agreement or the Plan. 
 1.
DEFINITIONS AND CONSTRUCTION. 
 1.1
Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Grant Notice or the Plan. 
 1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Option Agreement. Except when otherwise
indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise. 
 2. TAX STATUS OF OPTION. 
 This Option is intended to be a Nonstatutory Stock Option and shall not be treated as an Incentive Stock Option within the meaning of Section 422(b)
of the Code. 
 3. ADMINISTRATION. 
 All questions of interpretation concerning this Option Agreement shall be determined by the Committee. All determinations by the Committee shall be final
and binding upon all persons having an interest in the Option. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, or election which is the responsibility of or which is allocated to
the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation, or election. 
  

 1 

 4. EXERCISE OF THE
OPTION. 
 4.1 Right to Exercise. Except as otherwise provided herein, the Option
shall be exercisable on and after the Initial Vesting Date and prior to the termination of the Option (as provided in Section 6) in an amount not to exceed the number of Vested Shares less the number of shares previously acquired upon exercise
of the Option. In no event shall the Option be exercisable for more shares than the Number of Option Shares, as adjusted pursuant to Section 9. 
 4.2 Method of Exercise. Exercise of the Option shall be by means of electronic or written notice (the “Exercise Notice”) in a form authorized by the Company.
An electronic Exercise Notice must be digitally signed or authenticated by the Participant in such manner as required by the notice and transmitted to the Company or an authorized representative of the Company (including a third-party administrator
designated by the Company). In the event that the Participant is not authorized or is unable to provide an electronic Exercise Notice, the Option shall be exercised by a written Exercise Notice addressed to the Company, which shall be signed by the
Participant and delivered in person, by certified or registered mail, return receipt requested, by confirmed facsimile transmission, or by such other means as the Company may permit, to the Company, or an authorized representative of the Company
(including a third-party administrator designated by the Company). Each Exercise Notice, whether electronic or written, must state the Participant’s election to exercise the Option, the number of whole shares of Stock for which the Option is
being exercised and such other representations and agreements as to the Participant’s investment intent with respect to such shares as may be required pursuant to the provisions of this Option Agreement. Further, each Exercise Notice must be
received by the Company prior to the termination of the Option as set forth in Section 6 and must be accompanied by full payment of the aggregate Exercise Price for the number of shares of Stock being purchased. The Option shall be deemed to be
exercised upon receipt by the Company of such electronic or written Exercise Notice and the aggregate Exercise Price. 
 4.3 Payment of
Exercise Price. 
 (a) Forms of Consideration Authorized. Except as otherwise provided below, payment of the
aggregate Exercise Price for the number of shares of Stock for which the Option is being exercised shall be made (i) in cash or by check or cash equivalent, (ii) if permitted by the Company, by tender to the Company, or attestation to the
ownership, of whole shares of Stock owned by the Participant having a Fair Market Value not less than the aggregate Exercise Price, (iii) by means of a Cashless Exercise, as defined in Section 4.3(b), or (iv) by any combination of the
foregoing. 
 (b) Limitations on Forms of Consideration. 
 (i) Tender of Stock. Notwithstanding the foregoing, the Option may not be exercised by tender to the Company, or attestation to the ownership, of
shares of Stock to the extent such tender or attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. If required by the Company, the Option may not be
exercised by tender to the Company, or attestation to the ownership, of shares of Stock unless such shares either have been owned by the Participant for more than six (6) months or such other period, if any, required by the Company (and not
used for another option exercise by attestation during such period) or were not acquired, directly or indirectly, from the Company. 
  

 2 

 (ii) Cashless Exercise. A “Cashless Exercise” means the
delivery of a properly executed notice together with irrevocable instructions to a broker in a form acceptable to the Company providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all of the shares of
Stock acquired upon the exercise of the Option pursuant to a program or procedure approved by the Company (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the
Board of Governors of the Federal Reserve System). The Company reserves, at any and all times, the right, in the Company’s sole and absolute discretion, to establish, decline to approve or terminate any such program or procedure, including with
respect to the Participant notwithstanding that such program or procedures may be available to others. 
 4.4 Tax
Withholding. At the time the Option is exercised, in whole or in part, or at any time thereafter as requested by the Company, the Participant hereby authorizes withholding from payroll and any other amounts payable to the
Participant, and otherwise agrees to make adequate provision for (including by means of a Cashless Exercise to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of
the Participating Company Group, if any, which arise in connection with the Option. The Company shall have no obligation to deliver shares of Stock until the tax withholding obligations of the Participating Company Group have been satisfied by the
Participant. 
 4.5 Beneficial Ownership of Shares; Certificate Registration. The Participant hereby authorizes the
Company, in its sole discretion, to deposit for the benefit of the Participant with any broker with which the Participant has an account relationship of which the Company has notice any or all shares acquired by the Participant pursuant to the
exercise of the Option. Except as provided by the preceding sentence, a certificate for the shares as to which the Option is exercised shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the
Participant. 
 4.6 Restrictions on Grant of the Option and Issuance of Shares. The grant of the Option and the issuance
of shares of Stock upon exercise of the Option shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect to such securities. The Option may not be exercised if the issuance of shares of Stock upon
exercise would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. In addition, the Option
may not be exercised unless (i) a registration statement under the Securities Act shall at the time of exercise of the Option be in effect with respect to the shares issuable upon exercise of the Option or (ii) in the opinion of legal
counsel to the Company, the shares issuable upon exercise of the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. THE PARTICIPANT IS CAUTIONED THAT THE OPTION MAY
NOT BE EXERCISED UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE PARTICIPANT MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED. The inability of the Company to obtain from any 
  

 3 

 regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to
the lawful issuance and sale of any shares subject to the Option shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to
the exercise of the Option, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with
respect thereto as may be requested by the Company. 
 4.7 Fractional Shares. The Company shall not be required to issue
fractional shares upon the exercise of the Option. 
 5. NONTRANSFERABILITY OF THE
OPTION. 
 During the lifetime of the Participant, the Option shall be exercisable only by the
Participant or the Participant’s guardian or legal representative. The Option shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the
Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. Following the death of the Participant, the Option, to the extent provided in Section 7, may be exercised by the
Participant’s legal representative or by any person empowered to do so under the deceased Participant’s will or under the then applicable laws of descent and distribution. 
 6. TERMINATION OF THE OPTION. 
 The Option shall terminate and may no longer be exercised after the first to occur of (a) the close of business on the Option Expiration Date,
(b) the close of business on the last date for exercising the Option following termination of the Participant’s Service as described in Section 7, or (c) a Change in Control to the extent provided in Section 8. 

7. EFFECT OF TERMINATION OF SERVICE.

 7.1 Option Exercisability. The Option shall terminate immediately upon the Participant’s termination of Service to the extent
that it is then unvested and shall be exercisable after the Participant’s termination of Service to the extent it is then vested only during the applicable time period as determined below and thereafter shall terminate. 
 (a) Disability. If the Participant’s Service terminates because of the Disability of the Participant, the Option, to the
extent unexercised and exercisable for Vested Shares on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal representative) at any time prior to the expiration
of twelve (12) months after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. 
 (b) Death. If the Participant’s Service terminates because of the death of the Participant, the Option, to the extent unexercised and exercisable for Vested Shares on the date on which the
Participant’s Service terminated, may be exercised by the Participant’s legal representative or other person who acquired the right to exercise the Option by reason of the Participant’s death at any time prior to the expiration of
twelve (12) months after the date on 
  

 4 

 which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. The
Participant’s Service shall be deemed to have terminated on account of death if the Participant dies within three (3) months after the Participant’s termination of Service. 
 (c) Termination After Change in Control. If the Participant’s Service ceases as a result of a Termination After Change in Control (as
defined below), then (i) the Option, to the extent unexercised and exercisable for Vested Shares on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal
representative) at any time prior to the expiration of six (6) months after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date, and (ii) the number of Vested Shares shall
be increased by an amount equal to twenty-five percent (25%) of the Number of Option Shares (but in no event to a number in excess of 100% of the Number of Option Shares) effective as of the date on which the Participant’s Service
terminated; provided, however, that if the Participant is an Employee serving on a part-time basis, such percentage increase in the number of Vested Shares shall be prorated on the basis of the relationship which the Participant’s part-time
Service bears to full-time Service in the same capacity. 
 (d) Other Termination of Service. If the Participant’s
Service terminates for any reason, except Disability, death or Termination After Change in Control, the Option, to the extent unexercised and exercisable for Vested Shares by the Participant on the date on which the Participant’s Service
terminated, may be exercised by the Participant within three (3) months after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. 
 7.2 Extension if Exercise Prevented by Law. Notwithstanding the foregoing, if the exercise of the Option within the applicable time
periods set forth in Section 7.1 is prevented by the provisions of Section 4.6, the Option shall remain exercisable until three (3) months after the date the Participant is notified by the Company that the Option is exercisable, but
in any event no later than the Option Expiration Date. 
 7.3 Extension if Participant Subject to Section 16(b). Notwithstanding
the foregoing, if a sale within the applicable time periods set forth in Section 7.1 of shares acquired upon the exercise of the Option would subject the Participant to suit under Section 16(b) of the Exchange Act, the Option shall remain
exercisable until the earliest to occur of (i) the tenth (10th) day following the date on which a sale of such shares by the Participant would no longer be subject to such suit, (ii) the one hundred and ninetieth (190th) day
after the Participant’s termination of Service, or (iii) the Option Expiration Date. 
 7.4 Certain Definitions. 

(a) “Termination After a Change in Control” shall mean either of the following events occurring upon or within twelve
(12) months after a Change in Control: 
 (i) termination by the Participating Company Group of the Participant’s Service for any
reason other than for Cause (as defined in the Plan); or 
  

 5 

 (ii) the Participant’s resignation from all capacities in which the Participant is then rendering
Service within a reasonable period of time following the event constituting a Constructive Termination (as defined below). 
 Notwithstanding any provision
herein to the contrary, Termination After a Change in Control shall not include any termination of the Participant’s Service which (1) is for Cause (as defined in the Plan); (2) is a result of the Participant’s death or
disability; (3) is a result of the Participant’s voluntary termination of Service other than upon a Constructive Termination; or (4) occurs prior to the effectiveness of a Change in Control. 
 (b) “Constructive Termination” shall mean any one or more of the following: 
 (i) without the Participant’s express written consent, the assignment to the Participant of any duties, or any limitation of the Participant’s
responsibilities, substantially inconsistent with the Participant’s positions, duties, responsibilities and status with a Participating Company immediately prior to the date of the Change in Control; 
 (ii) without the Participant’s express written consent, the relocation of the principal place of the Participant’s Service to a location that
is more than fifty (50) miles from the Participant’s principal place of Service immediately prior to the date of the Change in Control, or the imposition of travel requirements substantially more demanding of the Participant than such
travel requirements existing immediately prior to the date of the Change in Control; 
 (iii) any failure by a Participating Company to pay,
or any material reduction by a Participating Company of, (1) the Participant’s base salary in effect immediately prior to the date of the Change in Control, or (2) the Participant’s bonus compensation, if any, in effect
immediately prior to the date of the Change in Control (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned by the Participant); or 
 (iv) any failure by a Participating Company to (1) continue to provide the Participant with the opportunity to participate, on terms no less
favorable than those in effect for the benefit of any employee group which customarily includes a Person holding the employment position or a comparable position with the Participating Company then held by the Participant, in any benefit or
compensation plans and programs, including, but not limited to, the Participating Company’s life, disability, health, dental, medical, savings, profit sharing, stock purchase and retirement plans, if any, in which the Participant was
participating immediately prior to the date of the Change in Control, or their equivalent, or (2) provide the Participant with all other fringe benefits (or their equivalent) from time to time in effect for the benefit of any employee group
which customarily includes a Person holding the employment position or a comparable position with the Participating Company then held by the Participant. 
 8. EFFECT OF CHANGE IN CONTROL. 
 In the event of a Change in Control, the surviving, continuing, successor, or purchasing entity or parent thereof, as the case may be (the “Acquiror”), may, without the

  

 6 

 consent of the Participant, assume or continue in full force and effect the Company’s rights and obligations under
the Option or substitute for the Option a substantially equivalent option for the Acquiror’s stock. In the event the Acquiror elects not to assume or continue the Company’s rights and obligations under the Option or substitute for the
Option in connection with the Change in Control, and provided that the Participant’s Service has not terminated prior to the date of the Change in Control, the number of Vested Shares shall be increased by an amount equal to twenty-five percent
(25%) (or, if the Participant is an Employee serving on a part-time basis, such percentage shall be prorated on the basis of the relationship which the Participant’s part-time Service bears to full-time Service in the same capacity) of the
Number of Option Shares (but in no event to a number in excess of 100% of the Number of Option Shares) effective as of the date of the Change in Control. Any exercise of the Option that was permissible solely by reason of this Section shall be
conditioned upon the consummation of the Change in Control. The Option shall terminate and cease to be outstanding effective as of the time of consummation of the Change in Control to the extent that the Option is neither assumed or continued by the
Acquiror in connection with the Change in Control nor exercised as of the date of the Change in Control. 
 9.
ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE. 
 Subject to any required action by the stockholders of the Company, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation,
reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the
Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of shares of Stock, appropriate
adjustments shall be made in the number, Exercise Price and kind of shares subject to the Option, in order to prevent dilution or enlargement of the Participant’s rights under the Option. For purposes of the foregoing, conversion of any
convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any fractional share resulting from an adjustment pursuant to this Section shall be rounded down to the nearest whole
number, and in no event may the Exercise Price be decreased to an amount less than the par value, if any, of the stock subject to the Option. The Committee in its sole discretion, may also make such adjustments in the terms of the Option to reflect,
or related to, such changes in the capital structure of the Company or distributions as it deems appropriate. The adjustments determined by the Committee pursuant to this Section shall be final, binding and conclusive. 
 10. RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE
OR CONSULTANT. 
 The Participant shall have no rights as a stockholder with respect to
any shares covered by the Option until the date of the issuance of the shares for which the Option has been exercised (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No
adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date the shares are issued, except as provided in Section 9. If the Participant is an Employee, the Participant understands and
acknowledges that, except as otherwise provided in a separate, written employment 
  

 7 

 agreement between a Participating Company and the Participant, the Participant’s employment is “at will”
and is for no specified term. Nothing in this Option Agreement shall confer upon the Participant any right to continue in the Service of a Participating Company or interfere in any way with any right of the Participating Company Group to terminate
the Participant’s Service as a Director, an Employee or Consultant, as the case may be, at any time. 
 11.
LEGENDS. 
 The Company may at any time place legends referencing any applicable federal, state or
foreign securities law restrictions on all certificates representing shares of stock subject to the provisions of this Option Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates
representing shares acquired pursuant to the Option in the possession of the Participant in order to carry out the provisions of this Section. 
 12. ARBITRATION. 
 In the event a dispute between the parties to this Option Agreement
arises out of, in connection with, or with respect to this Option Agreement, or any breach of this Option Agreement, such dispute will, on the written request of one (1) party delivered to the other party, be submitted and settled by
arbitration in Fremont, California in accordance with the rules of the American Arbitration Association then in effect and will comply with the California Arbitration Act, except as otherwise specifically stated in this Section 12. Judgment
upon the award rendered by the arbitrators may be entered in any court having jurisdiction. The parties submit to the in personam jurisdiction of the Supreme Court of the State of California for the purpose of confirming any such award and entering
judgment upon the award. Notwithstanding anything to the contrary that may now or in the future be contained in the rules of the American Arbitration Association, the parties agree as follows: 
 12.1 Each party will appoint one individual approved by the American Arbitration Association to hear and determine the dispute within twenty
(20) days after receipt of notice of arbitration from the noticing party. The two (2) individuals so chosen will select a third impartial arbitrator. The majority decision of the arbitrators will be final and binding upon the parties to
the arbitration. If either party fails to designate its arbitrator within twenty (20) days after delivery of the notice provided for in this Section 12.1, then the arbitrator designated by the one (1) party will act as the sole
arbitrator and will be considered the single, mutually approved arbitrator to resolve the controversy. In the event the parties are unable to agree upon a rate of compensation for the arbitrators, they will be compensated for their services at a
rate to be determined by the American Arbitration Association. 
 12.2 The parties will enjoy, but are not limited to, the same rights to
discovery as they would have in the United States District Court for the Northern District of California. 
 12.3 The arbitrators will, upon
the request of either party, issue a written opinion of their findings of fact and conclusions of law. 
 12.4 Upon receipt by the requesting
party of said written opinion, said party will have the right within ten (10) days to file with the arbitrators a motion to reconsider, and 
  

 8 

 upon receipt of a timely request the arbitrators will reconsider the issues raised by said motion and either confirm or
change their majority decision which will then be final and binding upon the parties to the arbitration. 
 12.5 The arbitrators will award
to the prevailing party in any such arbitration reasonable expenses, including attorneys’ fees and costs, incurred in connection with the dispute. 
 13. MISCELLANEOUS PROVISIONS. 
 13.1
Termination or Amendment. The Committee may terminate or amend the Plan or the Option at any time; provided, however, that except as provided in Section 8 in connection with a Change in Control, no such termination or amendment may
adversely affect the Option or any unexercised portion hereof without the consent of the Participant unless such termination or amendment is necessary to comply with any applicable law or government regulation. No amendment or addition to this
Option Agreement shall be effective unless in writing. 
 13.2 Further Instruments. The parties hereto agree to execute such further
instruments and to take such further action as may reasonably be necessary to carry out the intent of this Option Agreement. 
 13.3
Binding Effect. Subject to the restrictions on transfer set forth herein, this Option Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and
assigns. 
 13.4 Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or
permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Option Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at
the e-mail address, if any, provided for the Participant by a Participating Company, or upon deposit in the U.S. Post Office or foreign postal service, by registered or certified mail, or with a nationally recognized overnight courier service, with
postage and fees prepaid, addressed to the other party at the address of such party set forth in the Grant Notice or at such other address as such party may designate in writing from time to time to the other party. 
 (a) Description of Electronic Delivery. The Plan documents, which may include but do not necessarily include: the Plan, the Grant
Notice, this Option Agreement, the Plan Prospectus, and any reports of the Company provided generally to the Company’s stockholders, may be delivered to the Participant electronically. In addition, the Participant may deliver electronically the
Grant Notice and Exercise Notice called for by Section 4.2 to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not
necessarily include the delivery of a link to a Company intranet or the internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

 (b) Consent to Electronic Delivery. The Participant acknowledges that the Participant has read Section 13.4(a) of this Option
Agreement and consents to the 
  

 9 

 electronic delivery of the Plan documents and the delivery of the Grant Notice and Exercise Notice, as described in
Section 13.4(a). The Participant acknowledges that he or she may receive from the Company a paper copy of any documents delivered electronically at no cost to the Participant by contacting the Company by telephone or in writing. The Participant
further acknowledges that the Participant will be provided with a paper copy of any documents if the attempted electronic delivery of such documents fails. Similarly, the Participant understands that the Participant must provide the Company or any
designated third party administrator with a paper copy of any documents if the attempted electronic delivery of such documents fails. The Participant may revoke his or her consent to the electronic delivery of documents described in
Section 13.4(a) or may change the electronic mail address to which such documents are to be delivered (if Participant has provided an electronic mail address) at any time by notifying the Company of such revoked consent or revised e-mail
address by telephone, postal service or electronic mail. Finally, the Participant understands that he or she is not required to consent to electronic delivery of documents described in Section 13.4(a). 
 13.5 Integrated Agreement. The Grant Notice, this Option Agreement and the Plan, together with any employment, service or other agreement between
the Participant and a Participating Company referring to the Option, shall constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein and supersede any
prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter. To the extent contemplated herein, the provisions of the Grant Notice, the
Option Agreement and the Plan shall survive any exercise of the Option and shall remain in full force and effect. 
 13.6 Applicable
Law. This Option Agreement shall be governed by the laws of the State of California as such laws are applied to agreements between California residents entered into and to be performed entirely within the State of California. 
 13.7 Counterparts. The Grant Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. 
  

 10 

	
	Participant:
                            
	
	Date:
                            

 STOCK OPTION EXERCISE NOTICE 
 PDL BioPharma, Inc. 
 Stock Administrator 
 34801 Campus Drive 
 Fremont, CA 94555 
 Ladies and Gentlemen: 
 1. Option. I was granted a nonstatutory stock option (the
“Option”) to purchase shares of the common stock (the “Shares”) of PDL BioPharma, Inc. (the “Company”) pursuant to the Company’s
2005 Equity Incentive Plan (the “Plan”), my Notice of Grant of Stock Option (the “Grant Notice”) and my Stock Option Agreement (the “Option
Agreement”) as follows: 
  

			
	 Date of Grant:
	  	___________
		
	 Number of Option Shares:
	  	___________
		
	 Exercise Price per Share:
	  	$                        

 2. Exercise of Option. I hereby elect to exercise the Option to purchase the
following number of Shares, all of which are Vested Shares in accordance with the Grant Notice and the Option Agreement: 
  

			
	 Total Shares Purchased:
	  	___________
		
	 Total Exercise Price (Total Shares X Price per Share)
	  	$                        

 3. Payments. I enclose payment in full of the total exercise price for the Shares in
the following form(s), as authorized by my Option Agreement: 
  

			
	 TM Cash:
	  	$                        
		
	 TM Check:
	  	$                        
		
	 TM Tender of Company Stock:
	  	Contact Plan Administrator

 4. Tax Withholding. I authorize payroll withholding and otherwise will make adequate
provision for the federal, state, local and foreign tax withholding obligations of the Company, if any, in connection with the Option. 
 5.
Participant Information. 
  

			
	My address is:	 	  

		
		 	  

		
	My Social Security Number is:	 	  

  

 1 

 6. Binding Effect. I agree that the Shares are being acquired in accordance with and
subject to the terms, provisions and conditions of the Grant Notice, the Option Agreement and the Plan, to all of which I hereby expressly assent. This Agreement shall inure to the benefit of and be binding upon my heirs, executors, administrators,
successors and assigns. 
  

	
	Very truly yours,
	
	  

	(Signature)

 Receipt of the above is hereby acknowledged. 
  

			
	PDL BIOPHARMA, INC.
		
	By:	 	  

		
	Title:	 	  

		
	Dated:	 	  

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]